Evidence map›Paper›PMID 31006015›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2020

Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline.

Katerina Damianaki, Joao Miguel Lourenco, Philippe Braconnier, Jean-Pierre Ghobril, Olivier Devuyst, Michel Burnier, Sebastien Lenglet, Marc Augsburger, Aurelien Thomas, Menno Pruijm

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Zinc deficiency contributes to blunted myogenesis in chronic kidney disease.American journal of physiology. Cell physiology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Type 2 diabetes mellitus and zinc dysregulation: From basic and epidemiological evidence to interventions.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Katerina DamianakiDepartment of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne Lausanne, Switzerland.
Joao Miguel LourencoDepartment of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne Lausanne, Switzerland.
Philippe BraconnierDepartment of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne Lausanne, Switzerland.
Jean-Pierre GhobrilDivision of Chronic Disease, University Institute of Social and Preventive Medicine, University Hospital of Lausanne, Lausanne, Switzerland.
Olivier DevuystInstitute of Physiology, University Hospital of Zürich, Zürich, Switzerland.
Michel BurnierDepartment of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne Lausanne, Switzerland.
Sebastien LengletUnit of Toxicology, CURML, Geneva University Hospitals, Lausanne University Hospital, Lausanne, Switzerland.
Marc AugsburgerUnit of Toxicology, CURML, Geneva University Hospitals, Lausanne University Hospital, Lausanne, Switzerland.
Aurelien ThomasUnit of Toxicology, CURML, Geneva University Hospitals, Lausanne University Hospital, Lausanne, Switzerland.
Menno PruijmDepartment of Medicine, Service of Nephrology and Hypertension, Lausanne University Hospital (CHUV) and University of Lausanne Lausanne, Switzerland.
University of Lausanne · CHUniversity Centre of Legal Medicine · CHUniversity Hospital of Lausanne · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZinc deficiency is commonly encountered in chronic kidney disease (CKD). The aims of this study were to assess whether zinc deficiency was related to increased renal excretion of zinc and to the progression of CKD.

methodsPlasma and 24-h urinary zinc levels, urinary electrolytes and uromodulin were measured in 108 CKD patients and 81 individuals without CKD. Serum creatinine values were collected for 3 years to calculate the yearly change in estimated glomerular filtration rate (eGFR). Multivariable regression analysis was performed to assess the association between baseline zinc levels and yearly change in eGFR.

resultsCKD patients had lower circulating zinc levels and higher 24-h urinary zinc excretion than non-CKD participants (612.4 ± 425.9 versus 479.2 ± 293.0 µg/day; P = 0.02). Fractional excretion (FE) of zinc was higher and it significantly increased at more advanced CKD stages. Zinc FE was correlated negatively with 24-h urinary uromodulin excretion (r=-0.29; P < 0.01). Lower baseline plasma zinc levels were associated with a faster yearly decline of renal function in age, gender, diabetes and hypertension adjusted models, but this relationship was no longer significant when baseline eGFR or proteinuria were included.

conclusionsZinc levels are lower in CKD, and not compensated by reduced renal zinc excretion. The inverse association between urinary zinc excretion and uromodulin possibly points to an impaired tubular activity, which could partly account for zinc imbalance in CKD. These data suggest that zinc status is associated with renal function decline, but further studies elucidating the underlying mechanisms and the potential role of zinc supplements in CKD are needed.

Indexed as

Case-Control StudiesCreatinineDisease ProgressionFemaleFollow-Up StudiesGlomerular Filtration RateHumansKidney Function TestsMaleMiddle AgedRenal Insufficiency, ChronicUromodulinZincCreatinineUromodulinZincCKDGFRuromodulinzinc excretionzinc renal handling

Identifiers

PMID31006015
OpenAlexW2936414910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.